0000899243-17-005786.txt : 20170301 0000899243-17-005786.hdr.sgml : 20170301 20170301160553 ACCESSION NUMBER: 0000899243-17-005786 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170227 FILED AS OF DATE: 20170301 DATE AS OF CHANGE: 20170301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Prothena Corp plc CENTRAL INDEX KEY: 0001559053 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ADELPHI PLAZA STREET 2: UPPER GEORGE'S STREET CITY: DUN LAOGHAIRE, CO. DUBLIN STATE: L2 ZIP: A96 T927 BUSINESS PHONE: 011-353-1-236-2500 MAIL ADDRESS: STREET 1: ADELPHI PLAZA STREET 2: UPPER GEORGE'S STREET CITY: DUN LAOGHAIRE, CO. DUBLIN STATE: L2 ZIP: A96 T927 FORMER COMPANY: FORMER CONFORMED NAME: Neotope Corp Ltd DATE OF NAME CHANGE: 20120926 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HENNEY CHRISTOPHER S CENTRAL INDEX KEY: 0001242880 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35676 FILM NUMBER: 17654092 MAIL ADDRESS: STREET 1: 10505 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-02-27 0 0001559053 Prothena Corp plc PRTA 0001242880 HENNEY CHRISTOPHER S C/O PROTHENA BIOSCIENCES INC 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Ordinary Shares, par value $0.01 per share 2017-02-27 4 M 0 5989 6.65 A 5989 D Ordinary Shares, par value $0.01 per share 2017-02-27 4 S 0 5989 57.1632 D 0 D Stock Option (right to buy) 6.65 2017-02-27 4 M 0 5989 0.00 D 2023-03-18 Ordinary Shares 5989 20000 D The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person. The transaction was executed in multiple trades in prices ranging from $57.00 to $57.80, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. The shares subject to the option are fully vested and exercisable as of the date hereof. /s/ A.W. Homan, as Attorney-in-Fact for Christopher S. Henney 2017-03-01